Xtant Medical Holdings (FRA:XMS) Marketable Securities: €0.0 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

FRA:XMS Xtant Medical Holdings Inc FRA:XMS
27 GF Score
Price €0.38
GF Value €0.53
! 4 Warning Signs
View Full Analysis

What is Xtant Medical Holdings Marketable Securities?

Xtant Medical Holdings FRA:XMS -3.57% 27 Marketable Securities is €0.0 Mil as of Mar. 2026. GuruFocus rates FRA:XMS with a GF Score™ of 27/100 and a GF Value™ of €0.53. The stock has 4 warning signs investors should review.

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price. Xtant Medical Holdings's Marketable Securities for the quarter that ended in Mar. 2026 was €0.0 Mil.

Xtant Medical Holdings  (FRA:XMS) Marketable Securities Explanation

Marketable Securities are very liquid as they tend to have maturities of less than one year. Furthermore, the rate at which these securities can be bought or sold has little effect on their prices.

Please note, GuruFocus' Marketable Securities also includes "Other Short Term Investment".

Xtant Medical Holdings Marketable Securities Related Terms

Xtant Medical Holdings Marketable Securities Historical Data

* Premium members only.

The historical data trend for Xtant Medical Holdings's Marketable Securities can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xtant Medical Holdings Marketable Securities Chart

Xtant Medical Holdings Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Marketable Securities
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Xtant Medical Holdings Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
Marketable Securities Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
FRA:XMS
27GF Score
Xtant Medical Holdings Inc FRA:XMS
Marketable Securities is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xtant Medical Holdings Marketable Securities Calculation

Marketable Securities are very liquid securities that can be converted into cash quickly at a reasonable price.

Frequently Asked Questions Learn more about Marketable Securities →
What does a Marketable Securities of €0.0 Mil mean?
Xtant Medical Holdings (FRA:XMS) has a Marketable Securities of €0.0 Mil as of Mar. 2026. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xtant Medical Holdings and its competitors.
Is Xtant Medical Holdings' Marketable Securities too high?
Xtant Medical Holdings' current Marketable Securities is €0.0 Mil. Overall, Xtant Medical Holdings has a GF Score™ of 27/100, reflecting its overall financial health beyond just this single metric.
How does Xtant Medical Holdings' Marketable Securities compare to POSC and LUNG?
Xtant Medical Holdings' Marketable Securities of €0.0 Mil can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Marketable Securities for a Medical Devices & Instruments company?
A good Marketable Securities depends on the Medical Devices & Instruments industry context. However, Marketable Securities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Marketable Securities mean?
A high Marketable Securities can signal that a stock is expensive relative to its fundamentals. Marketable securities are high-liquid securites not directly classified as cash or cash equivalents. View historical data on Xtant Medical Holdings and its competitors. Xtant Medical Holdings's current Marketable Securities is €0.0 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xtant Medical Holdings stock overvalued right now?
Xtant Medical Holdings (FRA:XMS) has a current Marketable Securities of €0.0 Mil. The stock's GF Value™ is €0.53, compared to a current price of €0.38 — trading 28.7% below its estimated fair value. The current Marketable Securities is €0.0 Mil. Xtant Medical Holdings' overall GF Score™ is 27/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Marketable Securities calculated?
Marketable Securities is calculated from a company's financial statements. For Xtant Medical Holdings (FRA:XMS), the current Marketable Securities is €0.0 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xtant Medical Holdings (FRA:XMS) Overvalued in 2026?

Based on GuruFocus' analysis, Xtant Medical Holdings stock appears to be undervalued. The current stock price of €0.38 is trading 28.7% below its estimated GF Value™ of €0.53.

Key valuation signals for FRA:XMS:

  • Marketable Securities: €0.0 Mil
  • GF Value™: €0.53 vs. price of €0.38 (28.7% below fair value)
  • GF Score™: 27/100 with 4 warning signs

No single metric tells the full story. See the FRA:XMS stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Xtant Medical Holdings Business Description

Other Exchanges XTNT:USA
Address 664 Cruiser Lane, Belgrade, MT, USA, 59714
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the U.S.
27GF Score

Get the complete analysis for FRA:XMS

Marketable Securities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

€0.38
Price
€0.53
GF Value